First Time Loading...

Idorsia Ltd
SIX:IDIA

Watchlist Manager
Idorsia Ltd Logo
Idorsia Ltd
SIX:IDIA
Watchlist
Price: 2.312 CHF 7.04%
Updated: May 14, 2024

Idorsia Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Idorsia Ltd
Revenue Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Idorsia Ltd
SIX:IDIA
Revenue
CHf97.1m
CAGR 3-Years
60%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf14.8m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$371.2m
CAGR 3-Years
709%
CAGR 5-Years
160%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf157.6m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%
Kuros Biosciences AG
SIX:KURN
Revenue
CHf33.6m
CAGR 3-Years
103%
CAGR 5-Years
116%
CAGR 10-Years
N/A

See Also

What is Idorsia Ltd's Revenue?
Revenue
97.1m CHF

Based on the financial report for Dec 31, 2022, Idorsia Ltd's Revenue amounts to 97.1m CHF.

What is Idorsia Ltd's Revenue growth rate?
Revenue CAGR 5Y
-9%

Over the last year, the Revenue growth was 175%. The average annual Revenue growth rates for Idorsia Ltd have been 60% over the past three years , -9% over the past five years .